Discordant effects of a soluble VEGF receptor on wound healing and angiogenesis (original) (raw)

• Carmeliet P, Jain RK . Angiogenesis in cancer and other diseases. Nature 2000; 407: 249–257.
  Article CAS PubMed Google Scholar
• Losordo DW et al. Phase 1/2 placebo-controlled, double-blind, dose-escalating trial of myocardial vascular endothelial growth factor 2 gene transfer by catheter delivery in patients with chronic myocardial ischemia. Circulation 2002; 105: 2012–2018.
  Article CAS PubMed Google Scholar
• Henry TD et al. The VIVA trial: vascular endothelial growth factor in ischemia for vascular angiogenesis. Circulation 2003; 107: 1359–1365.
  Article CAS PubMed Google Scholar
• Rajagopalan S et al. Adenovirus-mediated gene transfer of VEGF(121) improves lower-extremity endothelial function and flow reserve. Circulation 2001; 104: 753–755.
  Article CAS PubMed Google Scholar
• Rivard A et al. Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF. Am J Pathol 1999; 154: 355–363.
  Article CAS PubMed PubMed Central Google Scholar
• Lederman RJ et al. Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trial. Lancet 2002; 359: 2053–2058.
  Article CAS PubMed Google Scholar
• Takeshita S et al. Intramuscular administration of vascular endothelial growth factor induces dose-dependent collateral artery augmentation in a rabbit model of chronic limb ischemia. Circulation 1994; 90: 228–234.
  Google Scholar
• Ferrara N, Alitalo K . Clinical applications of angiogenic growth factors and their inhibitors. Nat Med 1999; 5: 1359–1364.
  Article CAS PubMed Google Scholar
• Yancopoulos GD et al. Vascular-specific growth factors and blood vessel formation. Nature 2000; 407: 242–248.
  Article CAS PubMed Google Scholar
• Gale NW, Yancopoulos GD . Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development. Genes Dev 1999; 13: 1055–1066.
  Article CAS PubMed Google Scholar
• Kuo CJ et al. Comparative evaluation of the antitumor activity of antiangiogenic proteins delivered by gene transfer. Proc Natl Acad Sci USA 2001; 98: 4605–4610.
  Article CAS PubMed PubMed Central Google Scholar
• Davidoff AM, Leary MA, Ng CY, Vanin EF . Gene therapy-mediated expression by tumor cells of the angiogenesis inhibitor flk-1 results in inhibition of neuroblastoma growth in vivo. J Pediatr Surg 2001; 36: 30–36.
  Article CAS PubMed Google Scholar
• Millauer B et al. Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature 1994; 367: 576–579.
  Article CAS PubMed Google Scholar
• Mori A et al. Soluble Flt-1 gene therapy for peritoneal metastases using HVJ-cationic liposomes. Gene Therapy 2000; 7: 1027–1033.
  Article CAS PubMed Google Scholar
• Takayama K et al. Suppression of tumor angiogenesis and growth by gene transfer of a soluble form of vascular endothelial growth factor receptor into a remote organ. Cancer Res 2000; 60: 2169–2177.
  CAS PubMed Google Scholar
• Lai CM et al. Inhibition of angiogenesis by adenovirus-mediated sFlt-1 expression in a rat model of corneal neovascularization. Hum Gene Ther 2001; 12: 1299–1310.
  Article CAS PubMed Google Scholar
• Singer AJ, Clark RA . Cutaneous wound healing. N Engl J Med 1999; 341: 738–746.
  Article CAS PubMed Google Scholar
• Nissen NN et al. Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing. Am J Pathol 1998; 152: 1445–1452.
  CAS PubMed PubMed Central Google Scholar
• Frank S et al. Regulation of vascular endothelial growth factor expression in cultured keratinocytes. Implications for normal and impaired wound healing. J Biol Chem 1995; 270: 12607–12613.
  Article CAS PubMed Google Scholar
• Brown LF et al. Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing. J Exp Med 1992; 176: 1375–1379.
  Article CAS PubMed Google Scholar
• Chua Jr SC et al. Phenotypes of mouse diabetes and rat fatty due to mutations in the OB (leptin) receptor. Science 1996; 271: 994–996.
  Article CAS PubMed Google Scholar
• Jacobi J et al. Nicotine accelerates angiogenesis and wound healing in genetically diabetic mice. Am J Pathol 2002; 161: 97–104.
  Article CAS PubMed PubMed Central Google Scholar
• Greenhalgh DG, Sprugel KH, Murray MJ, Ross R . PDGF and FGF stimulate healing in the genetically diabetic mouse. Am J Pathol 1990; 136: 1235–1246.
  CAS PubMed PubMed Central Google Scholar
• Arnold F, West DC . Angiogenesis in wound healing. Pharmacol Ther 1991; 52: 407–422.
  Article CAS PubMed Google Scholar
• Folkman J . Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995; 1: 27–31.
  Article CAS PubMed Google Scholar
• Swift ME, Kleinman HK, DiPetro LA . Impaired wound repair and delayed angiogenesis in aged mice. Lab Invest 1999; 79: 1479–1487.
  CAS PubMed Google Scholar
• Tsou R et al. Retroviral delivery of dominant-negative vascular endothelial growth factor receptor type 2 to murine wounds inhibits wound angiogenesis. Wound Repair Regen 2002; 10: 222–229.
  Article PubMed Google Scholar
• Roman CD et al. Vascular endothelial growth factor-mediated angiogenesis inhibition and postoperative wound healing in rats. J Surg Res 2002; 105: 43–47.
  Article CAS PubMed Google Scholar
• Gelaw B, Levin S . Wound-induced angiogenesis and its pharmacologic inhibition in a murine model. Surgery 2001; 130: 497–501.
  Article CAS PubMed Google Scholar
• Haroon ZA et al. SU5416 delays wound healing through inhibition of TGF-beta 1 activation. Cancer Biol Ther 2002; 1: 121–126.
  Article CAS PubMed Google Scholar
• Ailawadi M et al. Adenovirus vector-mediated transfer of the vascular endothelial growth factor cDNA to healing abdominal fascia enhances vascularity and bursting strength in mice with normal and impaired wound healing. Surgery 2002; 131: 219–227.
  Article PubMed Google Scholar
• Deodato B et al. Recombinant AAV vector encoding human VEGF165 enhances wound healing. Gene Therapy 2002; 9: 777–785.
  CAS PubMed Google Scholar
• Romano di Peppe S et al. Adenovirus-mediated VEGF (165) gene transfer enhances wound healing by promoting angiogenesis in CD1 diabetic mice. Gene Therapy 2002; 9: 1271–1277.
  Article CAS PubMed Google Scholar
• Kirchner LM et al. Effects of vascular endothelial growth factor on wound closure rates in the genetically diabetic mouse model. Wound Repair Regen 2003; 11: 127–131.
  Article PubMed Google Scholar
• Galeano M et al. Adeno-associated viral vector-mediated human vascular endothelial growth factor gene transfer stimulates angiogenesis and wound healing in the genetically diabetic mouse. Diabetologia 2003; 46: 546–555.
  Article CAS PubMed Google Scholar
• Albert MR, Foster RA, Vogel JC . Murine epidermal label-retaining cells isolated by flow cytometry do not express the stem cell markers CD34, Sca-1, or Flk-1. J Invest Dermatol 2001; 117: 943–948.
  Article CAS PubMed Google Scholar